Metraipolis › archive › dc_67698d42d648

Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:41071055

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41071055
DOI
10.1093/ecco-jcc/jjaf181
License (as archived)
solo-consultazione
Archived
2026-11-08T20:40:19.014Z
SHA-256 of the archived text
d8e214627c7d3077ad4009c38571384a355ee9e8faa378c63e8f04184cff5fbb
Stable URL of this page
https://metraipolis.com/documento/dc_67698d42d648

How to cite

Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:41071055 — Europe PMC (en), https://europepmc.org/article/MED/41071055 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_67698d42d648 (Metraipolis archive dc_67698d42d648, sha256 d8e214627c7d3077ad4009c38571384a355ee9e8faa378c63e8f04184cff5fbb)
BibTeX
@misc{dc67698d42d648,
  title = {Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:41071055},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41071055},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_67698d42d648; sha256 d8e214627c7d3077ad4009c38571384a355ee9e8faa378c63e8f04184cff5fbb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41071055. Agents can read the archived copy with the MCP tool read_document.